Who owns Pds Biotechnology Ord?
- Ticker: PDSB
- CUSIP Number: 70465t107
Tip: Access positions for across all investors
Analyze quarterly positions in Pds Biotechnology Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pds Biotechnology Ord stock
Who bought or sold Pds Biotechnology Ord this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Capital Management | 1.7M | $1.5M | 4% | Jun 2026 |
|
| Colony | 642k | $566k | 100% | Jun 2026 |
|
| Quantinno Capital Management | 642k | $566k | 100% | Jun 2026 |
|
| BlackRock | 608k | $535k | 10% | Jun 2026 |
|
| Geode Capital Management | 587k | $517k | -11% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 357k | $315k | 16% | Jun 2026 |
|
| Citadel Advisors | 348k | $307k | 2982% | Jun 2026 |
|
| Militia Capital Management | 332k | $292k | 100% | Jun 2026 |
|
| Caption Management | 319k | $281k | 0% | Jun 2026 |
|
| William Blair $ Company | 300k | $264k | 0% | Jun 2026 |
|
| Jane Street | 280k | $246k | 100% | Jun 2026 |
|
| Renaissance Technologies | 252k | $222k | 14% | Jun 2026 |
|
| Integrys Wealth Advisors | 189k | $165k | 4% | Jun 2026 |
|
| Marshall Wace | 147k | $130k | 100% | Jun 2026 |
|
| State Street Corporation | 133k | $81k | 0% | Mar 2026 |
|
| Northern Trust | 127k | $112k | 16% | Jun 2026 |
|
| Wells Fargo & Company | 109k | $96k | -1% | Jun 2026 |
|
| Commonwealth Equity Services | 93k | $82k | 2% | Jun 2026 |
|
| Amussen Hunsaker & Associates | 70k | $62k | -6% | Jun 2026 |
|
| Bank of New York Mellon | 69k | $60k | -1% | Jun 2026 |
|
| Tempus Wealth Planning | 62k | $55k | 0% | Jun 2026 |
|
| Two Sigma Securities | 41k | $37k | 31% | Jun 2026 |
|
| Susquehanna International | 36k | $32k | 65% | Jun 2026 |
|
| Raymond James Financial | 34k | $30k | 230% | Jun 2026 |
|
| XTX Topco | 33k | $29k | -9% | Jun 2026 |
|
| ACT Capital Management | 30k | $26k | 0% | Jun 2026 |
|
| Advisor Group Holdings | 30k | $26k | 100% | Jun 2026 |
|
| Rockefeller Capital Management | 28k | $24k | 0% | Jun 2026 |
|
| Federation des caisses Desjardins du Quebec | 20k | $17k | 34% | Jun 2026 |
|
| Vanguard Global Advisers | 13k | $11k | 0% | Jun 2026 |
|
| United Capital Financial Advisers | 12k | $11k | 0% | Jun 2026 |
|
| Pnc Financial Services | 12k | $11k | 100% | Jun 2026 |
|
| UBS Group | 11k | $9.8k | -80% | Jun 2026 |
|
| SG Americas Securities | 10k | $9.0k | 100% | Jun 2026 |
|
| Goldman Sachs Group | 10k | $8.9k | 100% | Jun 2026 |
|
| Grandfield & Dodd | 10k | $8.8k | 0% | Jun 2026 |
|
| Davenport & Co | 10k | $8.8k | 0% | Jun 2026 |
|
| Tower Research Capital | 3.9k | $3.5k | 100% | Jun 2026 |
|
| Morgan Stanley | 3.9k | $2.0k | -20% | Mar 2026 |
|
| Group One Trading | 3.6k | $3.1k | 0% | Jun 2026 |
|
| Creative Financial Designs | 3.0k | $2.6k | 0% | Jun 2026 |
|
| Jones Financial Companies, L.L | 2.0k | $1.8k | 0% | Jun 2026 |
|
| Rialto Wealth Management | 761.00 | $670.973700 | 100% | Jun 2026 |
|
| Truvestments Capital | 655.00 | $576.989500 | 0% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 648.00 | $571.017600 | 0% | Jun 2026 |
|
| Barclays | 582.00 | $512.974800 | 100% | Jun 2026 |
|
| Basecamp Wealth Advisors | 377.00 | $331.986200 | 0% | Jun 2026 |
|
| SBI Securities | 113.00 | $100.005000 | -4% | Jun 2026 |
|
| Royal Bank of Canada | 80.00 | $0 | 7% | Jun 2026 |
|
| Jpmorgan Chase & Co | 19.00 | $16.999300 | 100% | Jun 2026 |
|
| Beacon Investment Advisory Services | 5.00 | $5.000000 | 0% | Jun 2026 |
|
| Caitong International Asset Management | 1.00 | $1.000000 | 100% | Jun 2026 |
|
Who sold out of Pds Biotechnology Ord?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Armistice Capital | Mar 2026 | 174k | $105k |
| Nine Masts Capital | Mar 2026 | 68k | $41k |
| Wealth Group | Mar 2026 | 13k | $8.0k |
| Simplex Trading | Mar 2026 | 271.00 | $163.006500 |